Which hedge funds own PLRX? PLIANT THERAPEUTICS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
7 of the hedge funds tracked by WhaleCreep disclosed a position in PLRX (PLIANT THERAPEUTICS INC) in their Q2 2026 13F filings, worth $7.9m in total. The largest holder by portfolio weight is Woodline Partners at 0.0% of its book. 1 exited: Bronte Capital.
7tracked managers holding
0opened this quarter
1exited this quarter
Which hedge funds hold PLRX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Woodline Partners | Q2 2026 | 0.0% | $1.5m | 1,296,534 | -22% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $2.3m | 2,049,874 | 11% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $2.4m | 2,142,226 | -34% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $952.0k | 835,124 | -16% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $637.8k | 559,447 | -53% | reduced |
| Tudor Investment | Q2 2026 | 0.0% | $33.9k | 29,729 | 0% | held |
| Point72 Asset Management LP | Q2 2026 | 0.0% | $22.9k | 20,073 | -57% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Bronte Capital | 0.1% | $23.5k |
How has hedge fund ownership of PLRX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 7 | $7.9m |
| Q1 2026 | 8 | $11.4m |
| Q4 2025 | 5 | $3.9m |
| Q3 2025 | 4 | $14.6m |
| Q2 2025 | 3 | $3.0m |
| Q1 2025 | 3 | $3.6m |
| Q4 2024 | 3 | $18.9m |
| Q3 2024 | 4 | $17.0m |
| Q2 2024 | 5 | $28.7m |
| Q1 2024 | 5 | $37.0m |
| Q4 2023 | 3 | $54.0m |
| Q3 2023 | 4 | $71.9m |
| Q2 2023 | 8 | $92.2m |
| Q1 2023 | 8 | $178.4m |
| Q4 2022 | 5 | $83.7m |
| Q3 2022 | 5 | $67.3m |
Counts every tracked manager that disclosed PLRX in that quarter's filing, including managers that have since stopped filing.